August 30, 2023
Swiss National Bank Decreases Holdings in Quaker Chemical Co.
According to the latest disclosure with the Securities & Exchange Commission, Swiss National Bank has reduced its holdings in specialty chemicals company Quaker Chemical Co. (NYSE:KWR) by 10.6% during the first quarter of this year. The institutional investor now owns 27,100 shares of the company’s stock, after selling 3,200 shares during the quarter. This constitutes approximately 0.15% of Quaker Chemical’s total worth, which amounts to $5,364,000 as of its most recent SEC filing.
Quaker Chemical Co., which is listed on the New York Stock Exchange under the ticker symbol KWR, recently announced its quarterly earnings data on August 1st. The company reported earnings per share (EPS) of $1.93 for the quarter, surpassing the consensus estimate of $1.85 by $0.08. Its revenue for the same period was recorded at $495.44 million as opposed to analyst estimates of $507.00 million.
Quaker Chemical’s net margin stood at 0.45%, and it posted a return on equity of 9.59%. In terms of year-over-year growth, the company experienced a modest increase in revenue of 0.6%. During the corresponding period last year, Quaker Chemical reported an EPS of $1.32.
This information has attracted considerable attention from research analysts in recent times who have commented on Quaker Chemical’s stock performance and future prospects. Royal Bank of Canada increased their target price for Quaker Chemical from $227.00 to $232.00 and gave it an “outperform” rating in a research report released on Thursday, August 3rd.
Stifel Nicolaus also provided coverage on Quaker Chemical and issued a “buy” rating with a target price set at $250.00 on Thursday, June 1st. Comparably, Deutsche Bank Aktiengesellschaft raised their price target for Quaker Chemical’s shares from $220.00 to $235.00 in a research report released on Monday, May 8th.
Additionally, StockNews.com initiated their coverage on Quaker Chemical on Thursday, August 17th with a “hold” rating assigned to the stock.
As we move forward in the current fiscal year, industry analysts predict that Quaker Chemical Co. will likely post earnings per share of 7.46.
In conclusion, Swiss National Bank has reduced its holdings in Quaker Chemical Co., an NYSE-listed specialty chemicals company. Despite this decrease in ownership, Quaker Chemical delivered positive quarterly earnings above consensus estimates and reported slight revenue growth. The company has garnered attention from various research analysts who have provided evaluation and ratings for its stock performance. Moving forward, it will be interesting to observe how Quaker Chemical continues to navigate any potential challenges and capitalizes on emerging opportunities within the specialty chemicals industry.
DISCLAIMER: This article is based on publicly available information, and should not be considered as financial advice or as a recommendation to buy or sell any securities mentioned.
Quaker Chemical Corporation
Updated on: 03/12/2023
Debt to equity ratio: Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
We did not find social sentiment data for this stock
There are no analysts data to display
Institutional Investors Show Confidence in Quaker Chemical as Stock Performance Remains Steady
Quaker Chemical Co. (NYSE:KWR) has attracted the attention of several institutional investors lately, with Morgan Stanley increasing its holdings by a staggering 299.6% during the fourth quarter. The investment firm now owns 482,199 shares of Quaker Chemical worth $80,479,000. This significant increase was due to the acquisition of an additional 361,525 shares in the last quarter alone.
Norges Bank also made a move to purchase a stake in Quaker Chemical during the fourth quarter, investing approximately $19,832,000. This further solidifies the interest and confidence of these institutional investors in the specialty chemicals company.
BlackRock Inc., another renowned institution in the investment world, boosted its stake in Quaker Chemical by 5.7% during the first quarter by acquiring an additional 115,746 shares. BlackRock now owns a total of 2,152,418 shares valued at $371,960,000.
Price T Rowe Associates Inc. MD followed suit during the second quarter by increasing its holdings in Quaker Chemical by 7.4%. The institution now possesses 1,359,780 shares worth $203,314,000 after adding an impressive 93,539 more shares.
Furthermore,Eaton Vance Management raised its stake in Quaker Chemical by an astonishing 28.9% during the first quarter after purchasing an additional 62,896 shares.This stands as yet another endorsement from reputable institutional investors,bolstering Quacker’s position within ths sector.The famed chemical company can take solace knowing that they affirm their own belief system juxtaposed against others.Predispo =ses themselves,to dominance,taking into account investor activity that is once again substantial enough to benefit them considerably.They must bear this success cautiously though,and be cognizant it could suddenly change for better or worse depending on future events and circumstances.
Considering these recent investments from notable institutional investors,it is clear that Quaker Chemical is gaining recognition for its potential and market value within the industry. This growing interest has also been reflected in the company’s stock performance.
As of Wednesday, August 30th, shares of NYSE:KWR opened at $169.65, continuing a steady trend within the chemical sector. With a 50-day moving average of $186.34 and a 200-day moving average of $192.00, Quaker Chemical has proven its ability to maintain stability in an ever-changing marketplace.
The specialty chemicals company boasts a strong financial standing with a decent debt-to-equity ratio of 0.65,a current ratio of 2.84, and a quick ratio of 2.05. Having reached a one-year low of $129.06 and a one-year high of $216.45, Quaker Chemical currently holds a market capitalization valued at $3.05 billion.
In light of recent research reports on Quaker Chemical, it becomes evident that analysts have taken notice and are offering positive ratings for the company’s future prospects.Royal Bank of Canada,in particular,elevated its target price from $227 to $232,reaffirming their “outperform” rating on Thursday,August 3rd.On top of that,Stifel Nicolaus initiated coverage on Quaker’s stock this June,giving it a “buy” rating set at $250.Deutsche Bank Aktiengesellschaft raised their price target to range between $220 and$235.Perhaps Stocknews.com resonates most with critics as they issued,and perhaps sternly advised,a cautions”Hold”rating.Their frustrating clinical insight reaffirms investor awareness on areas they may be exerting remote pressure.
Quaker Chemical recently announced an increase in their quarterly dividend payout starting October 31st.The dividend yield currently stands at an impressive rate of1:07%,significantly higher than their previous payout of $0.44.The company opted to raise its dividend to $0.455 per share and is expected to provide an annualized dividend of$1:82.
In recent news,Quaker Chemical’s executive vice president,Melissa Leneis,sold 4,445 shares of the company’s stock. The transaction took place on July 7th at an average price of $195.61 per share.The total value of the sale was approximately $869,486.45.Following this transaction, Leneis now holds 3,178 shares in Quaker Chemical, equivalent to approximately $621,648.58 in value.This disclosure was made through a document filed with the Securities and Exchange Commission(SEC),and details can be accessed on their official website.
It is worth mentioning that currently 1.30% of Quaker Chemical stock is owned by insiders within the company itself.This modest percentage emphasizes the trust that key personnel have in their own organization’s performance.Philosophically symbolizes their collective strength.
In conclusion,the surge of institutional interest from reputable investors such as Morgan Stanley,Norges Bank,and BlackRock Inc., among others, reflects positively on Quaker Chemical’s potential for growth and profitability.With a solid financial standing,stability,and positive research